Former U.S. FDA Official Says Congress Should Fix China API Problem
This article was originally published in PharmAsia News
Executive Summary
As far back as 1999, U.S. Congress pressed U.S. FDA to deal more effectively with a China-made drug believed to be contaminated and responsible for 17 deaths. In that case, an antibiotic was involved, but today Congress again is investigating why FDA was so late in becoming aware of the link between 19 deaths and a contaminated heparin ingredient produced in China. Former FDA Deputy Commissioner William Hubbard noted the similarities and said the incidents would be repeated "until Congress fixes this problem." (Click here for more